Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR): Efficacy and Toxicity of a Randomized Phase II Study of 11 Versus 29 Days Overall Treatment Time (PATRIOT Study; ClinicalTrials.gov NCT01423474)

Journal article

Open access

Peer reviewed

D.A. Loblaw, H.C. Quon, A.T. Ong, Y. Alayed, P. Cheung, W. Chu, H.T. Chung, D. Vesprini, A. Chowdhury, D. Panjwani, …

International journal of radiation oncology, biology, physics, Vol.105(1), pp.S56-S56

01/09/2019

Files and links (1)

url

https://doi.org/10.1016/j.ijrobp.2019.06.491View

Published (Version of record) Open

1 Record Views

Title: Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR): Efficacy and Toxicity of a Randomized Phase II Study of 11 Versus 29 Days Overall Treatment Time (PATRIOT Study; ClinicalTrials.gov NCT01423474)
Creators - without role: D.A. Loblaw - Sunnybrook Health Science Centre
H.C. Quon - University of Calgary
A.T. Ong - CancerCare Manitoba
Y. Alayed - University of Toronto
P. Cheung - Sunnybrook Health Science Centre
W. Chu - Sunnybrook Health Science Centre
H.T. Chung - Sunnybrook Health Science Centre
D. Vesprini - Sunnybrook Health Science Centre
A. Chowdhury - CancerCare Manitoba
D. Panjwani - BC Cancer Agency
G. Pang - Sunnybrook Health Science Centre
R. Korol - Sunnybrook Health Science Centre
M.T. Davidson - University of Toronto
A. Ravi - Sunnybrook Health Science Centre
B. McCurdy - University of Manitoba
L. Zhang - Sunnybrook Health Science Centre
A. Mamedov - Sunnybrook Health Science Centre
A. Deabreu - Sunnybrook Health Science Centre
Publication Details: International journal of radiation oncology, biology, physics, Vol.105(1), pp.S56-S56
Publisher: Elsevier Inc
Identifiers: 9951217608331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article